See also this year's filing and all EDGAR filings for this company.
PDF Report 0001586105_2015_Zyla_Life_Sciences.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001586105, Zyla Life Sciences
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,126,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 184,000 |
| 2 | PropertyPlantAndEquipmentNet | 4,417,000 |
| 3 | remainder_Assets | 843,000 |
| 4 | LiabilitiesCurrent | 7,429,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,880,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,661,000 |
| 9 | ResearchAndDevelopmentExpense | 22,395,000 |
| 10 | remainder_Expenses | 47,000 |
| 11 | remainder_Revenues | 1,920,000 |
| 12 | remainder_NetIncome | -6,031,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,296,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 60,570,000 |
| 1 | Liabilities | 16,309,000 |
| 2 | Expenses | 39,103,000 |
| 3 | Revenues | 1,920,000 |
| 4 | StockholdersEquity | 44,261,000 |
| 5 | NetIncome | -43,214,000 |
| 6 | ComprehensiveNetIncome | -43,862,000 |
| 7 | BaseVar | 62,614,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.37 |
| 9 | EconomicCapitalRatio | 2.58 |
Edgar->Model Mapping
Feature Distribution
